Company Announcements

In January, Battelle announced a strategic investment in CosmosID, which is a metagenomics software company focused on environmental biosurveillance and microbial identification.

CLC bio announced that software sales increased 30% in 2011, and operating profit grew more than 50% to over $1 million. A total of 1,500 organizations own licenses to its software, which is a 52% increase. Forty-five percent of sales were generated in the US.

CLC bio announced a collaboration to integrate its server- and desktop-based sequence analysis software with SciEngines’ RIVYERA platform for massively parallel computing.

In January, Knome appointed Martin Tolar, MD, PhD, as CEO. He was formerly CEO of Normoxys.

In January, Appistry announced a strategic partnership with the University of Missouri for next-generation sequencing (NGS) and bioinformatics.

Appistry named Trevor Heritage vice president of Sales and Marketing in January. He was previously executive vice president of Software Products at Accelrys.

TIBCO Software and ChemAxon integrated their respective Spotfire Analysis Platform and Instant JChem data management application.

Product Introductions

For NGS, Partek introduced Partek Flow for upstream alignment, QA/QC and quantification, and Partek Pathway for the contextualization of the gene relationship identified with Partek Genomics Suite.

Genedata released in January the Genedata Screener 10, featuring faster processing times and a new Cell Population Extension for multiplate cell population analysis.

Genedata launched the Genedata Screener Time-Series Extension for screening data analysis and management. It directly imports time-series data from instruments.

Simcyp extended its Simcyp Simulators of animal models to include a virtual mouse for use in cancer and toxicology research.

In January, Oracle Health Sciences introduced the Omics Data Bank molecular data model, which provides integration and analysis of cross-platform omics data to support translational research.

Ingenuity Systems released the stand-alone, $495 Ingenuity iReport for the statistical analysis and biological interpretation of gene expression data. It supports both RNA-Seq and microarray data.

Elsevier launched Reaxys Xcelerate, a premium version of Reaxys, which provides information on chemical compounds and reactions.

In February, Agilent introduced the next generation of its Enterprise Edition compliance services software for instrument qualification for the pharmaceutical industry.